Press Release

Materialise (NASDAQ: MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, announced today a strategic partnership with Kapstone Medical, a product development and intellectual property service provider for medical device innovators. The new partnership will provide medical device companies and surgeon inventors a complete solution for bringing ideas to market from initial idea to product launch.

For over 25 years, Materialise has been on the leading edge of 3D printing and image-based software solutions with its Mimics Innovation Suite.  In addition, its Anatomical Data Mining (ADaM) solution has been able to help orthopedic device manufacturers bring anatomical evidence into product development with validated, population-based average models derived from databases of imaging data.

Kapstone Medical is an end-to-end customized solutions provider dedicated to helping medical device innovators develop and safeguard their ideas. The company integrates a suite of disciplines to give physician inventors, entrepreneurs, and manufacturers of all sizes the opportunity to efficiently develop new ideas, on time and on budget.

“We are excited to join Kapstone Medical in a partnership that will help companies and inventors create a better and healthier world,” said Bryan Crutchfield, Managing Director of Materialise USA.

In the past year, Materialise and Kapstone have partnered to support Shoulder Options, Inc. in the concept design for a novel reconstructive device.  By combining Materialise’s population analysis service and Kapstone’s broad expertise in product development and commercialization, the two companies were able to assist Shoulder Options in successfully designing a next generation, anatomical implant system.

For John Kapitan, Kapstone Founder and President, “in layering the Materialise suite of products with Kapstone’s knowledge and skillset, the partnership will help innovators swiftly and efficiently take their technologies from conceptualization to market.”

For more information on the new partnership, please visit us at AAOS at booth #5156 (Materialise) or #2239 (Kapstone) or at the Materialise World Conference in Brussels, April 23 – 24.

For more information, please contact:

Abbey Delaney
North American Marketing Manager
Phone: (734) 259 – 7030
Email: abbey.delaney@materialise.com
Twitter: @MaterialiseNV
Visit: www.biomedical.materialise.com

 
About Materialise

With its headquarters in Leuven, Belgium, and branches worldwide, Materialise is a provider of Additive Manufacturing (AM) software solutions and sophisticated 3D printing services in a wide variety of industries, including healthcare, automotive, aerospace, art and design and consumer products. Since 1990, Materialise has played an active role in AM for industrial and medical applications by providing medical image processing, surgical simulations, and unique solutions for its customers’ prototyping, production, and medical needs. For additional information, please visit: www.materialise.com

About Kapstone Medical

Kapstone Medical, LLC (www.kapstonemedical.com), a product development service provider and medical device firm headquartered in Charlotte, NC, has been helping innovators develop and safeguard their ideas since 2007. The company integrates a suite of in-house disciplines to give physician inventors, entrepreneurs, and manufacturers of all sizes the opportunity to efficiently develop new ideas, on time and on budget. Kapstone Medical’s range of services includes all aspects of product development, IP protection, regulatory, quality assurance, and supply chain management.